These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 420951)

  • 21. Clinical pharmacokinetics and pharmacodynamics of anticancer drugs in children.
    Rodman JH; Relling MV; Stewart CF; Synold TW; McLeod H; Kearns C; Stute N; Crom WR; Evans WE
    Semin Oncol; 1993 Feb; 20(1):18-29. PubMed ID: 8475406
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Population pharmacokinetics and pharmacodynamics of paclitaxel and carboplatin in ovarian cancer patients: a study by the European organization for research and treatment of cancer-pharmacology and molecular mechanisms group and new drug development group.
    Joerger M; Huitema AD; Richel DJ; Dittrich C; Pavlidis N; Briasoulis E; Vermorken JB; Strocchi E; Martoni A; Sorio R; Sleeboom HP; Izquierdo MA; Jodrell DI; Calvert H; Boddy AV; Hollema H; Féty R; Van der Vijgh WJ; Hempel G; Chatelut E; Karlsson M; Wilkins J; Tranchand B; Schrijvers AH; Twelves C; Beijnen JH; Schellens JH
    Clin Cancer Res; 2007 Nov; 13(21):6410-8. PubMed ID: 17975154
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High concordance of drug-induced human hepatotoxicity with in vitro cytotoxicity measured in a novel cell-based model using high content screening.
    O'Brien PJ; Irwin W; Diaz D; Howard-Cofield E; Krejsa CM; Slaughter MR; Gao B; Kaludercic N; Angeline A; Bernardi P; Brain P; Hougham C
    Arch Toxicol; 2006 Sep; 80(9):580-604. PubMed ID: 16598496
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antiangiogenic potency of various chemotherapeutic drugs for metronomic chemotherapy.
    Drevs J; Fakler J; Eisele S; Medinger M; Bing G; Esser N; Marmé D; Unger C
    Anticancer Res; 2004; 24(3a):1759-63. PubMed ID: 15274352
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Kinetic analysis of cell killing effect induced by cytosine arabinoside and cisplatin in relation to cell cycle phase specificity in human colon cancer and Chinese hamster cells.
    Ozawa S; Sugiyama Y; Mitsuhashi J; Inaba M
    Cancer Res; 1989 Jul; 49(14):3823-8. PubMed ID: 2736524
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phase I and pharmacokinetic study of 10-propargyl-10-deazaaminopterin, a new antifolate.
    Krug LM; Ng KK; Kris MG; Miller VA; Tong W; Heelan RT; Leon L; Leung D; Kelly J; Grant SC; Sirotnak FM
    Clin Cancer Res; 2000 Sep; 6(9):3493-8. PubMed ID: 10999734
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Individualized drug therapy.
    Daly AK
    Curr Opin Drug Discov Devel; 2007 Jan; 10(1):29-36. PubMed ID: 17265738
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antitumour agents.
    Aherne GW
    Contemp Issues Clin Biochem; 1985; 3():281-300. PubMed ID: 3915970
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetic principles of antineoplastic drug therapy.
    Allen LM
    J Clin Pharmacol; 1983; 23(2-3):71-81. PubMed ID: 6853745
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dose-dependent pharmacokinetics and cancer chemotherapy.
    Powis G; Ames MM; Kovach JS
    Cancer Chemother Pharmacol; 1981; 6(1):1-9. PubMed ID: 7023712
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Doxorubicin and 5-fluorouracil plasma concentrations and detectability in parotid saliva.
    Celio LA; DiGregorio GJ; Ruch E; Pace J; Piraino AJ
    Eur J Clin Pharmacol; 1983; 24(2):261-6. PubMed ID: 6840177
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predictive value of the ATP chemosensitivity assay in epithelial ovarian cancer.
    O'Meara AT; Sevin BU
    Gynecol Oncol; 2001 Nov; 83(2):334-42. PubMed ID: 11606094
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anticancer Drug Development: The Way Forward.
    Connors T
    Oncologist; 1996; 1(3):180-181. PubMed ID: 10387985
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adjuvant breast cancer therapy: current status and future strategies--growth kinetics and the improved drug therapy of breast cancer.
    Norton L
    Semin Oncol; 1999 Feb; 26(1 Suppl 3):1-4. PubMed ID: 10203263
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetic parameters: potential for and problems with their use as predictors of response to cancer chemotherapeutic agents.
    Creaven PJ
    Bull Cancer; 1979; 66(1):85-8. PubMed ID: 420951
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A mechanistic, predictive model of dose-response curves for cell cycle phase-specific and -nonspecific drugs.
    Gardner SN
    Cancer Res; 2000 Mar; 60(5):1417-25. PubMed ID: 10728708
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.